TrumpRx vs FEHB: When It Saves Federal Employees Money

Last Updated: June 28, 2026 Reading Time: 7 min

TrumpRx is real, it's getting a lot of press, and for most federal employees it will save you nothing. That's the honest headline. TrumpRx is a cash-pay discount site, it doesn't touch your FEHB coverage, and for the vast majority of prescriptions your FEHB copay already beats it. There's exactly one situation where it's a clear win, GLP-1 weight-loss drugs your plan won't cover, and a few places it's worth a price check. Here's the decision framework.

Key Takeaways

  • TrumpRx is cash-pay, not insurance. What you spend there does not count toward your FEHB deductible or out-of-pocket max.
  • For most drugs, especially generics, your FEHB copay wins. Don't assume TrumpRx is cheaper.
  • The clear exception: GLP-1 weight-loss drugs if your FEHB plan doesn't cover them (Wegovy ~$199 vs $728.53 retail).
  • That gap closes January 2027, when OPM requires all FEHB plans to cover at least one GLP-1.
  • TrumpRx is prohibited by state law in California and Massachusetts.

What TrumpRx Actually Is

TrumpRx.gov launched February 6, 2026, as the consumer-facing piece of Executive Order 14297 ("most-favored-nation" prescription drug pricing, signed May 2025). What it is:

  • A federal website that aggregates discounts, not a pharmacy or insurer.
  • It surfaces manufacturer coupon programs for about 43 brand-name drugs, plus GoodRx / Cost Plus / Amazon Pharmacy cash prices for 600+ generics (added May 2026).
  • It is not an FEHB program, not insurance, and not Medicare or Medicaid. The underlying EO targets Medicare and Medicaid pricing and doesn't mention FEHB at all.

So for a federal employee, TrumpRx is just another cash-discount option sitting alongside your FEHB pharmacy benefit, not part of it.

The Catch That Decides Most Cases

Here's the single fact that determines whether TrumpRx is worth it: TrumpRx payments don't count toward your FEHB deductible or out-of-pocket maximum.

If you're working toward your FEHB out-of-pocket cap (because of other ongoing medical costs), paying cash through TrumpRx is money that does nothing to advance you toward that cap. Every dollar through your FEHB plan does. For anyone with significant annual healthcare spending, that alone usually makes FEHB the right call even when the sticker price looks close.

When FEHB Wins (Most of the Time)

For generics and many brand drugs, your FEHB copay beats the TrumpRx cash price. A few verified examples:

Drug TrumpRx cash Typical FEHB Verdict for most feds
Diflucan (fluconazole) $14.06 brand ~$10 generic copay FEHB wins
Azulfidine $99.60 ~$60 generic FEHB wins
Most common generics varies low generic copay FEHB usually wins
Wegovy (GLP-1), plan doesn't cover ~$199 intro (→$299) $728.53 retail TrumpRx wins

The Consumers' Checkbook analysis of 43 brand drugs against a nationwide FEHB PPO came back "mixed", meaning no blanket answer. The rule of thumb: check both prices, but expect FEHB to win on generics.

When TrumpRx Actually Helps

There's one standout case and a couple of edge cases.

The standout: GLP-1 weight-loss drugs your plan won't cover. If your FEHB plan excludes a GLP-1 like Wegovy, Ozempic, or Zepbound for weight loss, or buries it behind prior authorization you can't meet, the TrumpRx cash price (around $199 introductory, rising to roughly $299) is far below paying full retail. One FEHB plan listed Wegovy at $728.53. That's a real, large saving.

The edge cases:

  • A drug your plan doesn't cover at all (non-formulary), where any cash discount beats 100% retail.
  • A drug stuck behind prior authorization while you need it now.

Two important caveats: this GLP-1 gap narrows in January 2027, when OPM's 2027 call letter requires every FEHB plan to cover at least one GLP-1 drug (with a behavioral-therapy prior-auth step). And TrumpRx is prohibited by state law in California and Massachusetts, so feds there can't use it.

The Bigger FEHB Drug-Cost Story

TrumpRx is the headline, but two real policy changes will affect your drug costs more:

  • OPM's 2027 call letter (March 2026): all FEHB plans must cover at least one GLP-1 weight-loss drug plus two oral anti-obesity meds in 2027. See our FEHB 2027 changes guide.
  • CAA 2026 PBM reform (signed February 2026): forces pharmacy benefit managers to pass through 100% of rebates and bans spread pricing for commercial plans, phasing in around 2028. Whether it reaches FEHB is unclear, FEHB is exempt from ERISA, so OPM would have to apply equivalent rules separately. No confirming OPM guidance exists yet.

The 5-Second Decision Rule

Before you use TrumpRx for any drug:

  1. Is it a generic? Your FEHB copay almost certainly wins. Use FEHB.
  2. Does your FEHB plan cover it? If yes, compare copay vs TrumpRx, FEHB usually wins and counts toward your cap.
  3. Is it a GLP-1 (or other drug) your plan won't cover? This is where TrumpRx earns its keep. Price-check it.
  4. In CA or MA? TrumpRx isn't available to you.

Compare Your FEHB Plan First

The bigger lever on your drug costs is picking the right FEHB plan during Open Season, not a cash-discount site. Use our free FEHB Premium Calculator to compare plans on total cost, then check TrumpRx only for the drugs your plan handles poorly. Compare FEHB plans.

Frequently Asked Questions

Does TrumpRx work with my FEHB plan?

No. TrumpRx is cash-pay, not insurance. What you pay through TrumpRx does NOT count toward your FEHB deductible or out-of-pocket maximum. You're choosing one or the other for a given fill, your FEHB copay, or the TrumpRx cash price, whichever is lower.

Is TrumpRx cheaper than my FEHB copay?

Usually not. For most generics and many brand drugs, your FEHB copay (especially on generics) beats the TrumpRx cash price. TrumpRx wins mainly when your plan doesn't cover a drug at all, or imposes prior-authorization you can't clear. The clearest case is GLP-1 weight-loss drugs.

What's the GLP-1 angle with TrumpRx?

If your FEHB plan doesn't cover a GLP-1 like Wegovy, TrumpRx's cash price (around $199 intro, rising to ~$299) beats paying full retail (one FEHB plan listed Wegovy at $728.53). This gap narrows in January 2027, when OPM's call letter requires all FEHB plans to cover at least one GLP-1 drug.

What is TrumpRx, exactly?

TrumpRx.gov is a federal website launched February 6, 2026 under Executive Order 14297 (most-favored-nation drug pricing). It doesn't sell drugs, it aggregates manufacturer coupons for 43 brand drugs plus GoodRx/Cost Plus/Amazon Pharmacy prices for 600+ generics. It's not an FEHB or Medicare program. Note: it's prohibited by state law in California and Massachusetts.